98
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Heart Failure and Iron Deficiency Anemia in Italy: Results From CARMES-1 Registry

, , , , , , , , & show all
Pages 437-444 | Published online: 14 May 2013

References

  • Gheorghiade M , ZannadF, SopkoGet al. Acute heart failure syndromes: current state and framework for future research. Circulation , 112, 3958–3968 (2005).
  • Adams FK , FonarowGC, EmermanCLet al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. , 149, 209–216 (2005).
  • Cleland JG , SwedebergK, FollathFet al. The Euroheart Failure Survey programme: a survey on the quality of care among patients with heart failure in Europe: part I patients characteristics and diagnosis. Eur. Heart J. , 24, 442–463 (2003).
  • Di Lenarda A , ScherilloM, MaggioniAPet al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds – the TEMISTOCLE study. Am. Heart J. , 146(4), 1–10 (2003).
  • Fabbri G , GoriniM, MaggioniAP, CacciatoreG, Di Lenarda A. IN-CHF: il registro italiano dello scompenso cardiaco. Dieci ani di esperienza. G. Ital. Cardiol., 7(10), 689–694 (2006).
  • Tavazzi L , MaggioniAP, LucciDet al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J. , 27, 1207–1215 (2006).
  • Tang YD , KatzS. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation, 113(20), 2454–2461 (2006).
  • Silverberg D , WexlerD, BlumMet al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J. Am. Coll. Cardiol. , 35(7), 1737–1744 (2000).
  • Nanas JN , MatsoukaC, KarageorgopoulosDet al. Etiology of anemia in patients with advanced heart failure. JAAC , 48, 2485–2489 (2006).
  • Anand I , McMurrayJJ, WhitmoreJet al. Anemia and its relationship to clinical outcome in heart failure. Circulation , 110, 149–154 (2004).
  • Toblli JE , LombrañaA, DuarteP, Di Gennaro F. Intravenous iron reduces NT proBNP in anemic patients with chronic heart failure and renal insufficiency. JACC, 50, 1657–1665 (2007).
  • Okonko DO , GrzesloA, WitkowskiTet al. Effect of intravenous iron sucrose on exercise tolerance in anemic and non anemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF a randomized controlled observer-blinded trial. JACC , 51, 103–112 (2008).
  • Anker S , ColetJet al.,Filippatos G Ferric carboxymaltose in patients with heart failure and iron deficiency. N. Engl. J. Med., 361, 1–13 (2009).
  • Ponikowski P , MacdougallI, ColetJCet al. The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study. Circulation , 22, A17341 (2010).
  • Bailie GR , MasonNA, ValaorasTG. Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Hemodila. Int., 14(1), 47–54 (2010).
  • Groenveld HF , JanuzziJL, DammanKet al. Anemia and mortality in heart failure patients: a systematic review and meta-analysis. JACC , 53, 818–827 (2008).
  • Okonko O , GrzesloA, WitkowskiTet al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J. Am. Coll. Cardiol. , 51, 2 (2008).
  • Jankowska EA , RozentrytP, WitkowskaAet al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. , 31(15), 1872–1880 (2010).
  • McMurray JJ , AdamopoulosS, AnkerS. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J., 33, 1787–1847 (2012).
  • van Veldhuissen DJ , DiksteinK, Cohen-SolalAet al. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. Eur. Heart J. , 28, 2208–2216 (2007).
  • Gahli JK , AnandIS, AbrahamWTet al. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia. Circulation , 117, 526–635 (2008).
  • Parissis JT , KoureaK, PanouFet al. Effects of darbopietina alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic cardiomyopathy. Am. Heart J. , 155(4), 751.e1–751.e7 (2008).
  • Kourea K , ParissisJT, FarmakisDet al. Effects of darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure. Eur. J. Cardiovasc. Prev. Rehabil. , 15, 365–369 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.